Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_007078.3(LDB3):c.1074C>T(p.Ala358Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0377 in 1,611,890 control chromosomes in the GnomAD database, including 1,352 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A358A) has been classified as Uncertain significance.
LDB3 (HGNC:15710): (LIM domain binding 3) This gene encodes a PDZ domain-containing protein. PDZ motifs are modular protein-protein interaction domains consisting of 80-120 amino acid residues. PDZ domain-containing proteins interact with each other in cytoskeletal assembly or with other proteins involved in targeting and clustering of membrane proteins. The protein encoded by this gene interacts with alpha-actinin-2 through its N-terminal PDZ domain and with protein kinase C via its C-terminal LIM domains. The LIM domain is a cysteine-rich motif defined by 50-60 amino acids containing two zinc-binding modules. This protein also interacts with all three members of the myozenin family. Mutations in this gene have been associated with myofibrillar myopathy and dilated cardiomyopathy. Alternatively spliced transcript variants encoding different isoforms have been identified; all isoforms have N-terminal PDZ domains while only longer isoforms (1, 2 and 5) have C-terminal LIM domains. [provided by RefSeq, Jan 2010]
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 10-86706708-C-T is Benign according to our data. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-86706708-C-T is described in CliVar as Benign. Clinvar id is 36443.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.071 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0569 is higher than 0.05.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Oct 29, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not providedBenign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Dilated cardiomyopathy 1CUncertain:1
Aug 21, 2014
Cytogenetics- Mohapatra Lab, Banaras Hindu University
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:case-control
- -
CardiomyopathyBenign:1
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation
- -
Myofibrillar myopathy 4Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Cardiovascular phenotypeBenign:1
Jul 15, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -